OUE Healthcare Limited (SGX:5WA)
Singapore · Delayed Price · Currency is SGD 0.0350
0.00 (0.00%)
At close: Jul 28, 2026
OUE Healthcare Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 152.39 | 150.28 | 159.32 | 119.8 | 19.67 | |
Revenue Growth | 1.41% | -5.67% | 32.99% | 509.18% | -1.58% |
Cost of Revenue | 38 | 36.11 | 37.59 | 18.19 | 5.09 |
Gross Profit | 114.39 | 114.17 | 121.73 | 101.61 | 14.57 |
Selling, General & Admin | 35.04 | 29.44 | 30.88 | 23.51 | 12.24 |
Other Operating Expenses | -0.73 | -1.02 | -2.27 | -0.54 | -1.05 |
Operating Expenses | 34.31 | 28.42 | 28.61 | 22.98 | 11.19 |
Operating Income | 80.07 | 85.75 | 93.12 | 78.63 | 3.39 |
Interest Expense | -24.02 | -28.42 | -26.55 | -19.27 | -3.95 |
Interest & Investment Income | 0.54 | 0.68 | 0.7 | 0.46 | 0.26 |
Earnings From Equity Investments | -6.15 | 1.28 | 1.69 | -1.47 | 12.65 |
Currency Exchange Gain (Loss) | -9.56 | -7.09 | -3.74 | -1.1 | -0.09 |
EBT Excluding Unusual Items | 40.88 | 52.21 | 65.22 | 57.24 | 12.25 |
Merger & Restructuring Charges | - | -0.03 | - | -0.83 | -0.75 |
Gain (Loss) on Sale of Investments | -0 | - | - | 3.14 | - |
Gain (Loss) on Sale of Assets | -7.54 | -0.2 | - | -0.71 | - |
Asset Writedown | -9.89 | -12.69 | 9.3 | -10.13 | -19.89 |
Legal Settlements | - | 1.3 | - | 1.02 | 6.69 |
Other Unusual Items | - | - | - | - | 109.97 |
Pretax Income | 23.45 | 40.59 | 74.52 | 49.74 | 108.28 |
Income Tax Expense | 14.88 | 14.94 | 17.01 | 17.24 | -2.67 |
Earnings From Continuing Operations | 8.57 | 25.65 | 57.51 | 32.5 | 110.95 |
Net Income to Company | 8.57 | 25.65 | 57.51 | 32.5 | 110.95 |
Minority Interest in Earnings | -25.45 | -31.65 | -49.46 | -28.1 | 0.43 |
Net Income | -16.87 | -6 | 8.05 | 4.39 | 111.38 |
Net Income to Common | -16.87 | -6 | 8.05 | 4.39 | 111.38 |
Net Income Growth | - | - | 83.27% | -96.06% | - |
Shares Outstanding (Basic) | 4,443 | 4,443 | 4,443 | 4,443 | 4,443 |
Shares Outstanding (Diluted) | 4,443 | 4,443 | 7,152 | 7,152 | 6,603 |
Shares Change | - | -37.87% | - | 8.32% | 48.60% |
EPS (Basic) | -0.00 | -0.00 | 0.00 | 0.00 | 0.03 |
EPS (Diluted) | -0.00 | -0.00 | 0.00 | 0.00 | 0.02 |
EPS Growth | - | - | 83.33% | -96.45% | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 54.8 | 60.11 | 65.05 | 51.01 | 3.14 |
Free Cash Flow Per Share | 0.01 | 0.01 | 0.01 | 0.01 | - |
Gross Margin | 75.06% | 75.97% | 76.41% | 84.82% | 74.11% |
Operating Margin | 52.54% | 57.06% | 58.45% | 65.64% | 17.23% |
Profit Margin | -11.07% | -4.00% | 5.05% | 3.67% | 566.38% |
Free Cash Flow Margin | 35.96% | 40.00% | 40.83% | 42.58% | 15.95% |
EBITDA | 80.71 | 86.2 | 93.58 | 79.1 | 4.27 |
EBITDA Margin | 52.96% | 57.36% | 58.74% | 66.03% | 21.71% |
D&A For EBITDA | 0.64 | 0.45 | 0.46 | 0.47 | 0.88 |
EBIT | 80.07 | 85.75 | 93.12 | 78.63 | 3.39 |
EBIT Margin | 52.54% | 57.06% | 58.45% | 65.64% | 17.23% |
Effective Tax Rate | 63.44% | 36.81% | 22.82% | 34.66% | - |